Astrazeneca PLC Price Today
Astrazeneca PLC
AZN
Healthcare
$215.36B
๐ฐ
Market Cap
46.0
๐ธ
Price to Earnings
$1.5
๐
EPS
+0
๐ณ
ESG
Consensus Recommendations
Buy Consensus
Buy |
20 |
Strong Buy |
10 |
Hold |
9 |
Sell |
0 |
Strong Sell |
0 |
AZN Price Forecast Target
69.4 ๐ 88.0 +27%
AZN EPS Forecast
1.5 ๐ 4.3 +186%
Financials
Profit Margin
14 %
Revenue Growth
6.0 %
Dividend
$ 1.45
Held Percent
0.0% - Insiders
17.2% - Institutions
82.8% - Public
Major Fund Holders
-
๐ฐ Price (T.Rowe) Associates Inc $4.1B
-
๐ฐ Wellington Management Group, LLP $3.7B
-
๐ฐ Primecap Management Company $3.2B
-
๐ฐ Capital International Investors $2.6B
-
๐ฐ FMR, LLC $1.6B
Stock Ideas
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and โฆDavid Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individโฆScott Ferguson Portfolio
With a strong background as a protรฉgรฉ of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with โฆMichael Platt Portfolio
Michael Platt is the founder and CEO of BlueCrest Capital Management, a global macro hedge fund with a focus on systematic trading strategies. Prior to starting BlueCrest, Platt worked as a portfolio manager and trader, gaining experience across gloโฆ๐ฎFAQ
Some Frequently Asked Questions.
The Astrazeneca PLC industry is Drug ManufacturersโGeneral
The Astrazeneca PLC sector is Healthcare
The Astrazeneca PLC forecasted predicted Price to Earnings PE ratio is 16.1
The Astrazeneca PLC Price to Earnings PE ratio is 46.0
The Market Capitalization of Astrazeneca PLC is $215.36B
There are total of 18613259036 float shares with 17.2% held by Institutions and 0.0% held by insiders
The MAstrazeneca PLC forecasted Earnings per Share EPS is $4.3
The Astrazeneca PLC Earnings per Share EPS is 1.5
The Astrazeneca PLC company has $35732000000 gross profits with 14 profit margins
The Astrazeneca PLC Earnings Growth is 4.087% with 4.05% quarterly earnings growth
The Astrazeneca PLC Revenue is $44485001216 with 0.06 revenue growth
The price target for Astrazeneca PLC stock is $88.0 for the high target and $66.5 for the low target
The consensus analyst recommendations for Astrazeneca PLC is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Astrazeneca PLC is Buy, with the following breakdown:
- Buy: 20
- Strong Buy: 10
- Hold: 9
- Sell: 0
- Strong Sell: 0
The Beta of Astrazeneca PLC is 0.2
The dividend of Astrazeneca PLC is $1.45
The dividend yield of Astrazeneca PLC is 0.020599999%
The biggest institutional and mutual fund holders of Astrazeneca PLC stock are
- Price (T.Rowe) Associates Inc
- Wellington Management Group, LLP
- Primecap Management Company
- Capital International Investors
The Astrazeneca PLC ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0